The Medicines Company Falls 10% Following Angiomax Court Hearing

The Medicines Company

tumbled nearly 10 percent Monday following a court hearing on Friday involving litigation with Hospira, Inc.

over MDCO's Angiomax drug . http://www.benzinga.com/analyst-ratings/analyst-color/14/11/5026570/the-medicines-company-surges-amid-credit-suisse-upgrade Opening arguments were expected on Tuesday according to MTSLNews:

Hospira, Inc. closed at $87.71 Monday, down 0.22 percent. The Medicines Company regained some of its losses later in the day and closed at $27.21, down 5.45 percent